Cancer Treatment and Research - Advances in Lymphoma Research
Latest Publications

TOTAL DOCUMENTS

10

(FIVE YEARS 0)

H-INDEX

2

(FIVE YEARS 0)

Published By Springer US

9781461368519, 9781461541295

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Adhesion molecules in non-Hodgkin’s lymphoma

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_9 ◽

1997 ◽

pp. 119-139

Author(s):

Philip T. Neff ◽

Bradley W. McIntyre

Keyword(s):

Adhesion Molecules ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma

Download Full-text

The phenomenon of multidrug resistance in non-Hodgkin’s lymphoma

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_8 ◽

1997 ◽

pp. 107-117 ◽

Author(s):

Thomas P. Miller ◽

Ellen M. Chase ◽

William S. Dalton ◽

Thomas M. Grogan

Keyword(s):

Multidrug Resistance ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma

Download Full-text

Histologic grading of nodular sclerosing Hodgkin’s disease: is it an independent prognostic factor?

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_3 ◽

1997 ◽

pp. 29-40 ◽

Author(s):

Barbara M. Osborne ◽

Carlos Bueso-Ramos

Keyword(s):

Prognostic Factor ◽

Hodgkin's Disease ◽

Hodgkin’S Disease ◽

Independent Prognostic Factor ◽

Histologic Grading ◽

Nodular Sclerosing

Download Full-text

Fludarabine phosphate in lymphoma: an important new therapeutic agent

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_1 ◽

1997 ◽

pp. 3-14 ◽

Author(s):

Peter McLaughlin ◽

Lester E. Robertson ◽

Michael J. Keating

Keyword(s):

Therapeutic Agent ◽

Fludarabine Phosphate

Download Full-text

High-dose chemotherapy in non-Hodgkin’s lymphoma

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_7 ◽

1997 ◽

pp. 87-103

Author(s):

Jean-Yves Blay ◽

Thierry O. Philip

Keyword(s):

Hodgkin’S Lymphoma ◽

High Dose Chemotherapy ◽

Hodgkin's Lymphoma ◽

High Dose ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma

Download Full-text

Mantle cell lymphomas

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_4 ◽

1997 ◽

pp. 41-50 ◽

Author(s):

M. Alma Rodriguez ◽

William C. Pugh

Keyword(s):

Download Full-text

Factors that influence prognosis of intermediate-grade lymphomas at relapse

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_6 ◽

1997 ◽

pp. 79-86 ◽

Author(s):

M. Alma Rodriguez

Keyword(s):

Intermediate Grade

Download Full-text

Can prognostic factors be applied in treatment selection for aggressive lymphoma patients?

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_5 ◽

1997 ◽

pp. 53-77 ◽

Author(s):

Bertrand Coiffier

Keyword(s):

Prognostic Factors ◽

Treatment Selection ◽

Aggressive Lymphoma ◽

Download Full-text

PCR monitoring of response in patients treated with high-dose chemotherapy for low-grade lymphoma

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_10 ◽

1997 ◽

pp. 141-160 ◽

Author(s):

John G. Gribben

Keyword(s):

High Dose Chemotherapy ◽

High Dose ◽

Download Full-text

2-Chlorodeoxyadenosine treatment of lymphoma

Cancer Treatment and Research - Advances in Lymphoma Research ◽

10.1007/978-1-4615-4129-5_2 ◽

1997 ◽

pp. 15-26 ◽

Author(s):

Alan Saven ◽

Lawrence D. Piro

Download Full-text